News

Michael Gold, MD, explored microneedling innovations, pulse wave technology for pigmentation, and the aesthetic effects of GLP-1 receptor agonists, including "Ozempic face" and skin laxity.

Catch up on coverage from the third day of the 2025 South Beach Symposium held in Miami Beach, Florida.

Advances in biologics, JAK inhibitors, and PDE4 inhibitors provide personalized options for psoriasis management.

Compliance with acne medications remains a challenge, but timely intervention can prevent severe skin damage.

Mona Shahriari, MD, FAAD advocates for improving diversity in clinical imagery and trials to enhance trust in patients with skin of color.

Many patients with severe AD are unaware of newer, more effective treatments.

A holistic yet time-efficient approach can help dermatologists recognize early joint pain symptoms associated with psoriasis.

A balanced approach to dermatologic care involves using steroids for flare-ups and switching to non-steroidal options for maintenance.

Chilukuri said devices should be user-friendly even in solo practice settings to maximize efficiency and usability.

Catch up on coverage from the second day of the 2025 South Beach Symposium held in Miami Beach, Florida.

Michael Gold, MD, explored medical and procedural acne treatments and the emerging role of exosomes in regenerative dermatology.

Traditional descriptions often cater to lighter skin, necessitating updates to better serve diverse populations.

Advanced wound healing techniques, including exosomes and polynucleotides, can enhance post-procedure recovery and reduce pigmentation issues.

Nanette Silverberg, MD, discusses new treatments for pediatric vitiligo, including JAK inhibitors and surgical advancements.

Proper nutrition and nutraceuticals can help to manage skin conditions such as acne, eczema, and psoriasis.

A patient-centered approach ensures that hair loss treatments align with individual goals and medical history.

His presentation at South Beach Symposium will feature Zirwas’ insights on JAK inhibitors, eczema treatments, and emerging therapies.

Goldberg noted combination treatments that integrate radiofrequency, ultrasound, and muscle stimulation could improve patient outcomes.

Catch up on coverage from the first day of the 2025 South Beach Symposium held in Miami Beach, Florida.

“The most important tip as a physician, when you talk to the patient, sit down. Even if you sit down for 5 minutes, it's worth almost 5 hours,’ Leon Kircik, MD, said in his interview with Dermatology Times at SBS 2025.

Nada Elbuluk, MD, MSc, emphasizes that medical treatments remain first-line for vitiligo, but stable cases may benefit from surgical options.

Ablon covered all aspects of getting involved in clinical research, such as budgeting, recruiting, and analyzing data.

Michael Gold, MD, shares why the South Beach Symposium remains a must-attend legacy event for dermatologists, blending education and innovation.

According to Silverberg, emotional resilience, social support, and purposeful activities help adolescents cope with acne-related stress.

Nanette Silverberg, MD, highlights new dermatology advancements and the significance of conferences like MOPD in shaping the future of treatment.

Study author Erin McClure, MD, discusses how IGSRT offers consistent NMSC recurrence rates across socioeconomic and comorbidity factors, reinforcing its role as a first-line treatment.

The initiative, created by Quoin, promotes educational resources and study updates about the rare disease.

Dermatology Times staff will be onsite covering SBS 2025 with expert insights, interviews, and breaking news.

In an interview ahead of the main event, Ablon shared her excitement for SBS and listening in on presentations from industry leaders.

At the Horizons in Advanced Practice meeting, Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP, presented a case of a woman aged 35 years with widespread eczematous lesions covering over 50% BSA and severe lichenification.